Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis.

This study evaluated the adjuvant Dimethyldioctyldecyl Ammonium Bromide (DDA) effect on the protective immunity induced by a combination of plasmids containing genes encoding antigens Ag85B, MPT-83, and ESAT-6 from Mycobacterium tuberculosis. The combined DNA vaccines in DDA resulted in significant increases in both specific IgG and splenic T-cell-derived Th1-type cytokine gamma interferon (IFN-gamma) production in response to the three purified antigens when compared to that of combined DNA vaccines in saline. Vaccines in DDA increased the protective efficacy of mice challenged with M. tuberculosis H37Rv as measured by reduced relative CFU counts in their lungs. Mice immunized with the combined DNA vaccines were shown to limit the growth of tubercle bacilli both in lungs and in spleens. Histopathological analyses showed that vaccinated mice had substantially improved postinfection lung pathology relative to the controls. We suggest that our combination of antigens together with DDA formulation may provide a new insight into tuberculosis prevention.

[1]  N. Reiner,et al.  The 19-kDa Mycobacterium tuberculosis Protein Induces Macrophage Apoptosis Through Toll-Like Receptor-21 , 2003, The Journal of Immunology.

[2]  D. Purdie,et al.  Prime Boost Vaccination Strategies: CD8 T Cell Numbers, Protection, and Th1 Bias1 , 2003, The Journal of Immunology.

[3]  R. G. Hewinson,et al.  Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs. , 2003, Vaccine.

[4]  P. Krammer,et al.  IFN-γ Represses IL-4 Expression via IRF-1 and IRF-2 , 2002 .

[5]  B. Haagmans,et al.  Protective Antiviral Immune Responses to Pseudorabies Virus Induced by DNA Vaccination Using Dimethyldioctadecylammonium Bromide as an Adjuvant , 2002, Journal of Virology.

[6]  K. Huygen,et al.  Improved Tuberculosis DNA Vaccines by Formulation in Cationic Lipids , 2002, Infection and Immunity.

[7]  R. G. Hewinson,et al.  Vaccination of Guinea Pigs with DNA Encoding the Mycobacterial Antigen MPB83 Influences Pulmonary Pathology but Not Hematogenous Spread following Aerogenic Infection with Mycobacterium bovis , 2002, Infection and Immunity.

[8]  H. McShane,et al.  Protective Immunity against Mycobacterium tuberculosis Induced by Dendritic Cells Pulsed with both CD8+- and CD4+-T-Cell Epitopes from Antigen 85A , 2002, Infection and Immunity.

[9]  G. Delogu,et al.  DNA Vaccine Combinations Expressing Either Tissue Plasminogen Activator Signal Sequence Fusion Proteins or Ubiquitin-Conjugated Antigens Induce Sustained Protective Immunity in a Mouse Model of Pulmonary Tuberculosis , 2002, Infection and Immunity.

[10]  M. Ferrari,et al.  Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization. , 2001, Vaccine.

[11]  P. Andersen,et al.  Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6 , 2001, Infection and Immunity.

[12]  Olivier Denis,et al.  Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting , 2001, Infection and Immunity.

[13]  E. Agger,et al.  Tuberculosis subunit vaccine development: on the role of interferon-gamma. , 2001, Vaccine.

[14]  M. Ferrari,et al.  Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. , 2001, Vaccine.

[15]  H. McShane,et al.  Enhanced Immunogenicity of CD4+ T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis , 2001, Infection and Immunity.

[16]  M. Horwitz,et al.  Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. G. Hewinson,et al.  Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  S. Morris,et al.  The immunogenicity of single and combination DNA vaccines against tuberculosis. , 2000, Vaccine.

[19]  T. Klabunde,et al.  Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines , 2000, Nature Structural Biology.

[20]  S. Gurunathan,et al.  DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.

[21]  G. Delogu,et al.  Immunogenicity of DNA Vaccines Expressing Tuberculosis Proteins Fused to Tissue Plasminogen Activator Signal Sequences , 1999, Infection and Immunity.

[22]  H. Vordermeier,et al.  Development of Diagnostic Reagents To Differentiate between Mycobacterium bovis BCG Vaccination and M. bovis Infection in Cattle , 1999, Clinical Diagnostic Laboratory Immunology.

[23]  I. Orme,et al.  Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  W. Britton,et al.  Differential Protective Efficacy of DNA Vaccines Expressing Secreted Proteins of Mycobacterium tuberculosis , 1999, Infection and Immunity.

[25]  C. Chintu,et al.  An African perspective on the threat of tuberculosis and HIV/AIDS—can despair be turned to hope? , 1999, The Lancet.

[26]  Alan D. Roberts,et al.  Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis , 1998, Infection and Immunity.

[27]  R. Appelberg,et al.  Adjuvant modulation of immune responses to tuberculosis subunit vaccines , 1997, Infection and immunity.

[28]  R. G. Hewinson,et al.  Heterogenous Expression of the Related MBP70 and MPB83 Proteins Distinguish Various Substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv , 1996, Scandinavian journal of immunology.

[29]  J. Pollock,et al.  Immunoblot analysis of humoral immune responses to Mycobacterium bovis in experimentally infected cattle: early recognition of a 26-kilodalton antigen. , 1994, Clinical and diagnostic laboratory immunology.

[30]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.